Skip to main content

Table 3 Comparison of intervention and control practices on delivery of preventive manoeuvres to eligible patients post intervention (N = 4501)

From: Cost savings associated with improving appropriate and reducing inappropriate preventive care: cost-consequences analysis

Preventive Manoeuvres

Proportion of Eligible Patients

 

Intervention (n = 2201)

Control (n = 2300)

Significance

A & B Manoeuvres

% (N)

% (N)

 

Folic Acid Pre-conception

15.4% (325)

4.9% (369)

.0001

Cessation Counselling

41.7% (571)

40.6% (549)

N.S.

Mammography 50 to 69

68.3% (325)

57.5% (358)

.005

Hypertension Treatment

79.7% (169)

82.7% (185)

N.S.

STD Screening

23.3% (382)

19.1% (366)

N.S.

BP Measurement

74.6% (1666)

72.5% (1781)

N.S.

FLU Vaccination

66.0% (692)

53.8% (652)

.0001

Cervical Cytology

66.2% (826)

60.2% (958)

.01

D Manoeuvres

   

Blood glucose screening

32.8% (1844)

38.7% (1980)

.0001

PSA Testing

30.6% (379)

30.0% (393)

N.S.

Mammography 40 to 49 1

11.6% (267)

9.1% (309)

N.S.

Chest X-Ray

3.7% (571)

4.9% (549)

N.S.

Urine proteinuria screening

16.5% (1772)

29.8% (1887)

.0001

  1. 1This was a grade D manoeuvre at the time of the study; the Canadian Task Force on Preventive Health Care has recently changed it to a Grade C manoeuvre.